I agree that this site is using cookies. You can find further informations here.
X
Ustyugova, Anastasia
42  results:
Search for persons X
?
1

Cost-Effectiveness of Empagliflozin in Patients With Diabet..:

Reifsnider, Odette S. ; Kansal, Anuraag R. ; Wanner, Christoph...
American Journal of Kidney Diseases.  79 (2022)  6 - p. 796-806 , 2022
Link: https://doi.org/10.1053/..
 
?
2

Empagliflozin reduces cardiorenal events, healthcare resour..:

Nyström, Thomas ; Toresson Grip, Emilie ; Gunnarsson, Joel...
Diabetes, Obesity and Metabolism.  25 (2022)  1 - p. 261-271 , 2022
Link: https://doi.org/10.1111/..
 
?
3

Healthcare resource utilization in patients treated with em..:

Sheu, Wayne H‐H ; Seino, Yutaka ; Tan, Elise Chia‐Hui...
Journal of Diabetes Investigation.  13 (2022)  5 - p. 810-821 , 2022
Link: https://doi.org/10.1111/..
 
?
4

Healthcare Resource Utilization and Costs for Empagliflozin..:

Thomsen, Reimar W. ; Christensen, Lotte W. B. ; Kahlert, Johnny...
Diabetes Therapy.  13 (2022)  11-12 - p. 1891-1906 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Cost-effectiveness of empagliflozin versus canagliflozin, d..:

Reifsnider, Odette S ; Kansal, Anuraag R ; Gandhi, Pranav K...
BMJ Open Diabetes Research & Care.  9 (2021)  1 - p. e001313 , 2021
Link: https://doi.org/10.1136/..
 
?
6

Cost-effectiveness of empagliflozin in patients with type 2..:

Ramos, Mafalda ; Men, Peng ; Wang, Xu..
Cost Effectiveness and Resource Allocation.  19 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
7

Cardiovascular Events, Acute Hospitalizations, and Mortalit..:

Thomsen, Reimar W. ; Knudsen, Jakob S. ; Kahlert, Johnny...
Journal of the American Heart Association.  10 (2021)  11 - p. , 2021
Link: https://doi.org/10.1161/..
 
?
8

Cost‐effectiveness of empagliflozin in the UK in an EMPA‐RE..:

Reifsnider, Odette S. ; Kansal, Anuraag R. ; Franke, Jennifer...
ESC Heart Failure.  7 (2020)  6 - p. 3910-3918 , 2020
Link: https://doi.org/10.1002/..
 
?
9

Effect of empagliflozin on exercise ability and symptoms in..:

Abraham, William T ; Lindenfeld, JoAnn ; Ponikowski, Piotr...
European Heart Journal.  42 (2020)  6 - p. 700-710 , 2020
Link: https://doi.org/10.1093/..
 
?
10

Long-Term Cost-Effectiveness Analyses of Empagliflozin Vers..:

Ramos, Mafalda ; Cummings, Michael H. ; Ustyugova, Anastasia...
Diabetes Therapy.  11 (2020)  9 - p. 2041-2055 , 2020
Link: https://doi.org/10.1007/..
 
?
11

Changes in SGLT2i and GLP-1RA real-world initiator profiles..:

Knudsen, Jakob S. ; Baggesen, Lisbeth M. ; Lajer, Maria...
PLOS ONE.  15 (2020)  3 - p. e0229621 , 2020
Link: https://doi.org/10.1371/..
 
?
12

Rationale and design of the EMPERIAL‐Preserved and EMPERIAL..:

Abraham, William T. ; Ponikowski, Piotr ; Brueckmann, Martina...
European Journal of Heart Failure.  21 (2019)  7 - p. 932-942 , 2019
Link: https://doi.org/10.1002/..
 
?
13

Cost-effectiveness Analysis of Empagliflozin in Japan Based..:

Kaku, Kohei ; Haneda, Masakazu ; Sakamaki, Hiroyuki...
Clinical Therapeutics.  41 (2019)  10 - p. 2021-2040.e11 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Comparison of Oral Anticoagulants for Stroke Prevention in ..:

Tervonen, Tommi ; Ustyugova, Anastasia ; Sri Bhashyam, Sumitra...
Value in Health.  20 (2017)  10 - p. 1394-1402 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Empagliflozin reduces cardiorenal events, healthcare resour..:

Nyström, Thomas ; Toresson Grip, Emilie ; Gunnarsson, Joel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092061/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15